Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

V. S. Renukuntla, N. Ramchandani, J. Trast, M. Cantwell, R. A. Heptulla

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S39-S40
JournalDiabetes Technology and Therapeutics
StatePublished - Feb 2016

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this